Efficacy News and Research

RSS
Submission of NDA for Istradefylline(KW-6002), an investigational anti-Parkinson's disease drug

Submission of NDA for Istradefylline(KW-6002), an investigational anti-Parkinson's disease drug

INVEGA granted positive opinion recommending approval in Europe

INVEGA granted positive opinion recommending approval in Europe

Resistance training gets employees with rotator cuff injuries back to work

Resistance training gets employees with rotator cuff injuries back to work

FDA approves INVEGA treatment for schizophrenia

FDA approves INVEGA treatment for schizophrenia

Sangamo BioSciences starts phase 2 trial of therapy diabetic neuropathy

Sangamo BioSciences starts phase 2 trial of therapy diabetic neuropathy

Novagali Pharma announces FDA clearance of trial for treatment of dry eye syndrome

Novagali Pharma announces FDA clearance of trial for treatment of dry eye syndrome

Increasing survival of organ transplant patients by reducing time interval for transported organs

Increasing survival of organ transplant patients by reducing time interval for transported organs

No evidence to support the use of Dan Shen for ischemic stroke

No evidence to support the use of Dan Shen for ischemic stroke

EPCA-2 testing more accurate way to identify cancer in the prostate

EPCA-2 testing more accurate way to identify cancer in the prostate

New treatment Candida fungi - fewer side effects

New treatment Candida fungi - fewer side effects

Wyeth Pharmaceuticals receives FDA approvable for Bazedoxifene for the prevention of postmenopausal osteoporosis

Wyeth Pharmaceuticals receives FDA approvable for Bazedoxifene for the prevention of postmenopausal osteoporosis

Researchers study the possible use of carboranes

Researchers study the possible use of carboranes

New data supports safety of ranolazine but not its effectiveness

New data supports safety of ranolazine but not its effectiveness

No evidence that antioxidant supplements interfere with therapeutic effects of chemotherapy agents

No evidence that antioxidant supplements interfere with therapeutic effects of chemotherapy agents

Ranolazine safe but not effective in reducing major cardiac events in ACS patients

Ranolazine safe but not effective in reducing major cardiac events in ACS patients

Abbott submits NDA for combination Niaspan/Simvastatin tablet

Abbott submits NDA for combination Niaspan/Simvastatin tablet

Virtual colonoscopy most cost-effective colon cancer screening test

Virtual colonoscopy most cost-effective colon cancer screening test

Pharmacyclics announces NDA for Xcytrin injection

Pharmacyclics announces NDA for Xcytrin injection

Lawmakers urged to provide much needed oversight of bioidentical hormones

Lawmakers urged to provide much needed oversight of bioidentical hormones

Schering-Plough plans phase III trials for novel selective antiplatelet therapy

Schering-Plough plans phase III trials for novel selective antiplatelet therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.